State Ledger
Company profile

Grace Therapeutics, Inc. CIK 1444192

Ticker
GRCE (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Princeton, NJ 08540
Fiscal year end
2026 (FY)
Market Data
Close
$2.01
Change
+$0.00
Change %
0.00%
Volume
595

GRCE · trading date Oct 13, 2026 · previous close $2.01 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$7.79M
Total assets
$66.65M
Total liabilities
$2.76M
Stockholders' equity
$63.90M
Cash & equivalents
$16.98M
Operating income
-$11.08M
Operating cash flow
-$8.87M
Capital expenditures
—

Fiscal year 2026, via 10-K filed 2026-06-18. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
4.1%
Equity / assets
95.9%
CapEx / revenue
—
Operating cash flow / net income
1.14×

Derived from the fiscal year 2026 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2026 — -$7.79M $66.65M $2.76M $63.90M
2025 — -$9.57M $71.99M $5.38M $66.61M
2024 — -$12.85M $73.30M $11.56M $61.74M
2023 — -$42.43M $79.12M $11.17M $67.96M
2022 $100.00M -$9.82M $128.62M $20.35M $108.27M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-18
Financials filed via
Form 10-K
filed 2026-06-18

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Princeton, NJ 08540
103 CARNEGIE CENTER
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:40 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New Jersey — Public Companies